Earnings History Data for Biogen (BIIB) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Biogen

Biogen is a leading biopharmaceutical company engaged in the research, development and marketing of targeted therapies for the treatment of cancer, autoimmune and inflammatory diseases. The company owns industry leading brands for the treatment of multiple sclerosis, next-generation treatments for hemophilia, and a deep clinical pipeline ranging from Alzheimer's disease, lupus nephritis to neuropathic pain.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
20-07-2022 PM 7:20 AM ET
(Jul 20)
BIIB Biogen 31,782 5.25 4.10 0.00 Biogen Non-GAAP EPS of $5.25 beats by $1.16, revenue of $2.59B beats by $110M, raises FY22 guidance
[7/20/2022 7:01 AM]
207.34 -12.92 
(-5.87%)
217.39 -2.87 
(-1.30%)
187.16 - 351.86 1,595,455 850,000 29,463
03-05-2022 PM 7:00 AM ET
(May 3)
BIIB Biogen 30,922 3.62 4.41 0.00 Biogen Non-GAAP EPS of $3.62 misses by $0.74, revenue of $2.53B beats by $30M
[5/3/2022 7:04 AM]
205.44 -1.88 
(-0.91%)
210.00 2.68 
(1.29%)
192.67 - 468.55 1,303,641 1,110,000 6,830
03-02-2022 PM 7:00 AM ET
(Feb 3)
BIIB Biogen Inc. 33,200 3.39 3.33 4.58 Biogen Non-GAAP EPS of $3.39 beats by $0.02, revenue of $2.74B beats by $120M
[2/3/2022 7:00 AM]
220.59 -4.37 
(-1.94%)
214.20 -10.76 
(-4.78%)
212.56 - 468.55 1,632,047 1,590,000 37,055
20-10-2021 PM 7:00 AM ET
(Oct 20)
BIIB Biogen Inc. 40,200 4.77 4.15 8.84 Biogen EPS beats by $0.68, beats on revenue, boost FY outlook
[10/20/2021 7:06 AM]
266.43 -1.69 
(-0.63%)
271.00 2.87 
(1.07%)
223.25 - 468.55 1,901,886 950,000 73,751
22-07-2021 PM 7:10 AM ET
(Jul 22)
BIIB Biogen Inc. 48,550 5.68 4.57 10.26 Biogen EPS beats by $1.08, beats on revenue
[7/22/2021 7:03 AM]
326.65 3.69 
(1.14%)
322.96 0.0 
(0.00%)
223.25 - 468.55 1,389,788 1,660,000 12,133
22-04-2021 PM 7:00 AM ET
(Apr 22)
BIIB Biogen Inc. 40,990 5.34 5.07 9.14 Biogen EPS beats by $0.39, beats on revenue
[4/22/2021 7:05 AM]
259.06 -10.79 
(-4.00%)
259.99 -9.86 
(-3.65%)
223.25 - 363.92 1,959,699 870,000 71,461
03-02-2021 PM 7:30 AM ET
(Feb 3)
BIIB Biogen Inc. 42,850 4.58 4.92 8.34 Biogen EPS misses by $0.18, beats on revenue
[2/3/2021 7:15 AM]
263.55 -14.17 
(-5.10%)
270.50 -7.22 
(-2.60%)
223.25 - 374.99 2,228,039 1,390,046 69,122
21-10-2020 PM 6:30 AM ET
(Oct 21)
BIIB Biogen Inc. 42,550 8.84 8.07 9.17 Biogen up 3% on earnings beat, guidance raised
[10/21/2020 7:11 AM]
269.24 2.12 
(0.80%)
264.01 -3.11 
(-1.16%)
221.56 - 374.99 1,595,333 894,862 52,022
22-07-2020 PM 7:25 AM ET
(Jul 22)
BIIB Biogen Inc. 46,000 10.26 7.97 9.15 Biogen EPS beats by $2.25, beats on revenue
[7/22/2020 7:07 AM]
282.96 2.77 
(0.99%)
285.20 5.01 
(1.79%)
215.78 - 374.99 656,540 1,205,017 73,379